The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
Open accessAbstract
Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of NF-κB-dependent proinflammatory mediators can provoke an accumulation of pathogenic inflammatory neutrophils and macrophages in the lung”
From COVID-19 and the human innate immune system (2021) · cites this paper as Xiong et al., 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A3A is expressed in lung epithelial cells, and, importantly, the A3A expression level is significantly stimulated by SARS-CoV-2 infection in patients47–49 (Supplementary Fig. S13A).”
From The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness (2022) · cites this paper as [49]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Cited by
Sorted by citations
Items 101–200 of 1,000
Marín-Palma, D., Tabares-Guevara, J. H., Zapata-Cardona, M. I., Flórez‐Álvarez, L., Yepes, L. M. R., Rugeles, M. T., Zapata, W., Hernández, J. C., & Taborda, N. A. (2021) · Molecules · doi:10.3390/molecules26226900 · Cited by 110
Rosa, B. A., Ahmed, M., Singh, D. K., Choreño-Parra, J. A., Cole, J., Jiménez-Álvarez, L. A., Rodríguez-Reyna, T. S., Singh, B., Gonzalez, O., Carrion, R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01829-4 · Cited by 106
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Siracusano, G., Pastori, C., & Lopalco, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01049 · Cited by 110
Kelleni, M. T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110982 · Cited by 106
COVID-19, cytokines, inflammation, and spices: How are they related?
Kunnumakkara, A. B., Rana, V., Parama, D., Banik, K., Girisa, S., Henamayee, S., Thakur, K. K., Dutta, U., Garodia, P., Gupta, S. C., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119201 · Cited by 107
Sugiyama, M., Kinoshita, N., Ide, S., Nomoto, H., Nakamoto, T., Saito, S., Ishikane, M., Kutsuna, S., Hayakawa, K., Hashimoto, M., et al. (2020) · Gene · doi:10.1016/j.gene.2020.145145 · Cited by 104
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome
Pandolfi, L., Fossali, T., Frangipane, V., Bozzinì, S., Morosini, M., D’Amato, M., Lettieri, S., Urtis, M., Toro, A. D., Saracino, L., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01343-z · Cited by 104
Auwul, M. R., Rahman, M. R., Göv, E., Shahjaman, M., & Moni, M. A. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab120 · Cited by 102
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes
Mellett, L., & Khader, S. A. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.10.004 · Cited by 105
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia
Temesgen, Z., Assi, M., Shweta, F., Vergidis, P. I., Rizza, S. A., Bauer, P. R., Pickering, B. W., Razonable, R. R., Libertin, C. R., Burger, C. D., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.08.038 · Cited by 104
Ratcliff, J., & Simmonds, P. (2021) · Virology · doi:10.1016/j.virol.2020.12.018 · Cited by 108
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Zhang, H.-Q., Cao, B., Cao, Q., Hun, M., Cao, L., & Zhao, M. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2263229 · Cited by 103
Self-citationNon‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
Robb, C. T., Goepp, M., Rossi, A. G., & Yao, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15206 · Cited by 104
Immune Response and COVID-19: A mirror image of Sepsis
López‐Collazo, E., Ortiz, J. A., Martín‐Quirós, A., & Aguirre, L. A. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48400 · Cited by 103
Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19
Zheng, H., Xu, M., Yang, C.-X., Tian, R.-R., Zhang, M., Li, J. J., Wang, X.-C., Ding, Z.-L., Li, G.-M., Li, X., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00457-4 · Cited by 103
Self-citationA diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood
Ng, D., Granados, A. C., Santos, Y. A., Servellita, V., Goldgof, G. M., Meydan, C., Sotomayor-González, A., Levine, A. G., Balcerek, J., Han, L. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe5984 · Cited by 103
Allegra, A., Gioacchino, M. D., Tonacci, A., Musolino, C., & Gangemi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134782 · Cited by 98
The Roles of Neutrophils in Cytokine Storms
Chan, L., Karimi, N., Morovati, S., Alizadeh, K., Kakish, J. E., Vanderkamp, S., Fazel, F., Napoleoni, C., Alizadeh, K., Mehrani, Y., et al. (2021) · Viruses · doi:10.3390/v13112318 · Cited by 102
Obesity and its impact on COVID-19
de Leeuw, A. J. M., Luttikhuis, M. A. M. O., Wellen, A. C., Müller, C., & Calkhoven, C. F. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02072-4 · Cited by 115
SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping
Kaur, G., Lungarella, G., & Rahman, I. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00250-8 · Cited by 102
Prasad, K., Khatoon, F., Rashid, S., Ali, N., Alasmari, A. F., Ahmed, M. Z., Alqahtani, A. S., Alqahtani, M. S., & Kumar, V. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.228 · Cited by 96
The cytokine storm and thyroid hormone changes in COVID-19
Croce, L., Gangemi, D., Ancona, G., Liboà, F., Bendotti, G., Minelli, L., & Chiovato, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01506-7 · Cited by 103
Pirfenidone: A novel hypothetical treatment for COVID-19
Seifirad, S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110005 · Cited by 94
Compartmental immunophenotyping in COVID-19 ARDS: A case series
Ronit, A., Berg, R. M. G., Bay, J. T., Haugaard, A. K., Ahlström, M. G., Burgdorf, K. S., Ullum, H., Rørvig, S. B., Kristiansen, K. T., Foss, N. B., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.09.009 · Cited by 97
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
Zizzo, G., & Cohen, P. L. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30340-4 · Cited by 99
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
Singh, R., Kang, A., Luo, X., Jeyanathan, M., Gillgrass, A. E., Afkhami, S., & Xing, Z. (2021) · The FASEB Journal · doi:10.1096/fj.202002662r · Cited by 101
Helal, M. A., Shouman, S., Abdelwaly, A., Elmehrath, A. O., Essawy, M., Sayed, S. M., Saleh, A. H., & El‐Badri, N. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1822208 · Cited by 96
Islam, A. B. M. M. K., & Khan, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-76404-8 · Cited by 94
What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Gudowska-Sawczuk, M., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073673 · Cited by 93
Barh, D., Tiwari, S., Weener, M. E., Azevedo, V., Góes-Neto, A., Gromiha, M. M., & Ghosh, P. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104051 · Cited by 90
Fahlberg, M. D., Blair, R. V., Doyle‐Meyers, L. A., Midkiff, C. C., Zenere, G., Russell‐Lodrigue, K., Monjure, C. J., Haupt, E., Penney, T., Lehmicke, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19967-4 · Cited by 85
Chen, H., Liu, W., Wang, Y., Liu, D., Zhao, L., & Yu, J. Q. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103500 · Cited by 90
COVID-19: Inflammatory Profile
Wang, Y., & Perlman, S. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-012417 · Cited by 93
Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes
Jain, R., Ramaswamy, S., Harilal, D., Uddin, M. J., Loney, T., Nowotny, N. R., Suwaidi, H. S. A., Varghese, R. M., Deesi, Z., AlKhajeh, A. S., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.016 · Cited by 87
Umemura, Y., Mitsuyama, Y., Minami, K., Nishida, T., Watanabe, A., Okada, N., Yamakawa, K., Nochioka, K., & Fujimi, S. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.055 · Cited by 89
Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID‐19 patients
Zeng, H., Chen, D., Yan, J., Yang, Q., Han, Q., Li, S.-S., & Cheng, L. (2020) · FEBS Journal · doi:10.1111/febs.15609 · Cited by 87
Chen, J., Cheong, C., Lan, L., Zhou, X., Liu, J., Lü, A., Cheung, W. K., & Zhang, L. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab325 · Cited by 91
Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
Pum, A., Ennemoser, M., Adage, T., & Kungl, A. J. (2021) · Biomolecules · doi:10.3390/biom11010091 · Cited by 89
Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84
Multi-Omics Approaches in Immunological Research
Chu, X., Zhang, B., Koeken, V. A. C. M., Gupta, M. K., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668045 · Cited by 87
The Key Role of Lysosomal Protease Cathepsins in Viral Infections
Scarcella, M., d’Angelo, D., Ciampa, M., Tafuri, S., Avallone, L., Pavone, L. M., & Pasquale, V. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169089 · Cited by 89
A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2
Kreis, N., Ritter, A., Louwen, F., & Yuan, J. (2020) · Cells · doi:10.3390/cells9081777 · Cited by 83
Varghese, P. M., Tsolaki, A. G., Yasmin, H., Shastri, A., Ferluga, J., Vatish, M., Madan, T., & Kishore, U. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152008 · Cited by 83
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Hemmat, N., Asadzadeh, Z., Ahangar, N. K., Alemohammad, H., Najafzadeh, B., Derakhshani, A., Baghbanzadeh, A., Baghi, H. B., Javadrashid, D., Najafi, S., et al. (2021) · Archives of Virology · doi:10.1007/s00705-021-04958-7 · Cited by 81
Teixeira, P. C., Dorneles, G. P., Filho, P. S., da Silva, I. M., Schipper, L. L., Postiga, I. A. L., Neves, C. A. M., Rodrigues, L. C., Peres, A., de Souto, J. T., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108125 · Cited by 83
Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Hazeldine, J., & Lord, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680134 · Cited by 86
Ning, Q., Wu, D., Wang, X., Xi, D., Chen, T., Chen, G., Wang, H., Lü, H., Wang, M., Zhu, L., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00907-1 · Cited by 86
Iontophoresis-driven microneedle patch for the active transdermal delivery of vaccine macromolecules
Zheng, Y., Ye, R., Gong, X., Yang, J., Liu, B., Xu, Y., Nie, G., Xie, X., & Jiang, L. (2023) · Microsystems & Nanoengineering · doi:10.1038/s41378-023-00515-1 · Cited by 81
Self-citationVillena, J., & Kitazawa, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00699 · Cited by 83
Li, C., Chen, J., Lv, S.-K., Li, J., Li, L., & Hu, X. (2021) · Mediators of Inflammation · doi:10.1155/2021/6635925 · Cited by 83
Manipulation of ACE2 expression in COVID-19
Chaudhry, F., Lavandero, S., Xie, X., Sabharwal, B., Zheng, Y., Correa, A. A., Narula, J., & Levy, P. D. (2020) · Open Heart · doi:10.1136/openhrt-2020-001424 · Cited by 83
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
Saris, A., Reijnders, T. D. Y., Nossent, E. J., Schuurman, A. R., Verhoeff, J., van Asten, S. D., Bontkes, H. J., Blok, S. G., Duitman, J., Bogaard, H. J., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216256 · Cited by 80
Suvarna, K., Biswas, D., Pai, M. G. J., Acharjee, A., Bankar, R., Palanivel, V., Salkar, A., Verma, A., Mukherjee, A., Choudhury, M., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.652799 · Cited by 74
Qudus, M. S., Tian, M., Sirajuddin, S., Liu, S., Afaq, U., Wali, M., Liu, J., Pan, P., Luo, Z., Zhang, Q., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28751 · Cited by 84
Self-citationLi, Y., Hou, G., Zhou, H., Wang, Y., Tun, H. M., Zhu, A., Zhao, J., Xiao, F., Liu, D., Liu, D., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00508-4 · Cited by 76
Ren, W., Lan, J., Ju, X., Gong, M., Long, Q., Zhu, Z., Yu, Y., Wu, J., Zhong, J., Zhang, R., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010053 · Cited by 74
Sheerin, D., Abhimanyu, A., Peton, N., Vo, W., Allison, C. C., Wang, X., Johnson, W. E., & Coussens, A. K. (2022) · iScience · doi:10.1016/j.isci.2022.104464 · Cited by 78
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Bonam, S. R., Kotla, N. G., Bohara, R. A., Rochev, Y. A., Webster, T. J., & Bayry, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101051 · Cited by 76
Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers
Zafer, M. M., El‐Mahallawy, H. A., & Ashour, H. M. (2021) · Microorganisms · doi:10.3390/microorganisms9010159 · Cited by 74
Molecular diagnostic assays for COVID-19: an overview
Habibzadeh, P., Mofatteh, M., Silawi, M., Ghavami, S., & Faghihi, M. A. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1884640 · Cited by 77
Beckmann, N. D., Comella, P., Cheng, E., Lepow, L., Beckmann, A. G., Tyler, S. R., Mouskas, K., Simons, N. W., Hoffman, G. E., Francoeur, N. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24981-1 · Cited by 71
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach
Moolamalla, S. T. R., Balasubramanian, R., Chauhan, R., Priyakumar, U. D., & Vinod, P. K. U. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105114 · Cited by 82
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
Tripathy, A. S., Vishwakarma, S., Trimbake, D., Gurav, Y. K., Potdar, V. A., Mokashi, N. D., Patsute, S. D., Kaushal, H., Choudhary, M. L., Tilekar, B. N., et al. (2021) · Archives of Virology · doi:10.1007/s00705-021-05247-z · Cited by 74
Lentz, S. A., Roginski, M. A., Montrief, T., Ramzy, M. M., Gottlieb, M. A., & Long, B. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.06.082 · Cited by 78
Chitin and chitosan as tools to combat COVID-19: A triple approach
Safarzadeh, M., Sadeghi, S., Azizi, M., Rastegari‐Pouyani, M., Pouriran, R., & Hoseini, M. H. M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.157 · Cited by 72
SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics
Karthik, R., Maity, S., Muthukumar, A. R., Kandala, S., Tomar, D., El‐Aziz, T. M. A., Allen, C., Sun, Y., Venkatesan, M., Madaris, T. R., et al. (2022) · iScience · doi:10.1016/j.isci.2021.103722 · Cited by 72
Han, Y., Jia, Z., Shi, J., Wang, W., & He, K. (2021) · Bioimpacts · doi:10.34172/bi.2021.23378 · Cited by 70
Cell-Mediated Immune Responses to COVID-19 Infection
Guihot, A., Litvinova, E., Autran, B., Debré, P., & Vieillard, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01662 · Cited by 70
Immunity and inflammatory biomarkers in COVID‐19: A systematic review
Iwamura, A. P. D., da Silva, M. R. T., Hümmelgen, A. L., Pereira, P. V. S., Falcai, Â., Grumach, A. S., Goudouris, E., Condino‐Neto, A., & Prando, C. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2199 · Cited by 71
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy
Pillaiyar, T., & Laufer, S. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00335 · Cited by 70
A scoping review of the pathophysiology of COVID-19
Marik, P. E., Iglesias, J. I., Varón, J., & Kory, P. D. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211048026 · Cited by 74
Antar, S. A., Saleh, M. A., & Al-Karmalawy, A. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121048 · Cited by 73
Sun, J., Ye, F., Wu, A., Yang, R., Pan, M., Sheng, J., Zhu, W., Mao, L., Wang, M., Xia, Z., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.593857 · Cited by 67
Mantovani, S., Daga, S., Fallerini, C., Baldassarri, M., Benetti, E., Picchiotti, N., Fava, F., Gallì, A., Zibellini, S., Bruttini, M., et al. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00157-1 · Cited by 65
Boroujeni, M. E., Sekrecka, A., Antonczyk, A., Hassani, S., Sekrecki, M., Nowicka, H., Łopacinska, N., Olya, A., Kluzek, K., Wesoły, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888897 · Cited by 74
Hasan, M. Z., Islam, S., Matsumoto, K., & Kawai, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-96110-3 · Cited by 69
Temesgen, Z., Burger, C. D., Baker, J., Polk, C. M., Libertin, C. R., Kelley, C. F., Marconi, V. C., Orenstein, R., Catterson, V. M., Aronstein, W. S., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00494-x · Cited by 70
COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications
Luks, A. M., & Swenson, E. R. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202004-327cme · Cited by 68
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Makaremi, S., Asgarzadeh, A., Kianfar, H., Mohammadnia, A., Asghariazar, V., & Safarzadeh, E. (2022) · Inflammation Research · doi:10.1007/s00011-022-01596-w · Cited by 68
Schön, M. P., Berking, C., Biedermann, T., Buhl, T., Erpenbeck, L., Eyerich, K., Eyerich, S., Ghoreschi, K., Goebeler, M., Ludwig, R. J., et al. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14169 · Cited by 67
Panda, B., Sharma, Y., Gupta, S., & Mohanty, S. (2021) · Life · doi:10.3390/life11080784 · Cited by 66
Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection
Kesmez Can, F., Özkurt, Z., Öztürk, N., & Sezen, S. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14970 · Cited by 66
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
Kumar, N., Mishra, B., Mehmood, A., Athar, M., & Mukhtar, M. S. (2020) · iScience · doi:10.1016/j.isci.2020.101526 · Cited by 63
Lee, J. S., Koh, J., Yi, K., Kim, Y., Park, S., Kim, S., Kim, S.-M., Park, S. H., Ju, Y. S., Choi, Y. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24807-0 · Cited by 63
CCR2 Signaling Restricts SARS-CoV-2 Infection
Vanderheiden, A., Thomas, J., Soung, A. L., Davis-Gardner, M. E., Floyd, K. A., Jin, F., Cowan, D. A., Pellegrini, K., Creanga, A., Pegu, A., et al. (2021) · mBio · doi:10.1128/mbio.02749-21 · Cited by 67
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in CellsPreprint
Andres, A. D., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B. P., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256776 · Cited by 67
The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression
Huang, W. C., Li, M., Luo, G., Wu, X., Su, B., Zhao, L., Zhang, S., Chen, X., Jia, M., Zhu, J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001327 · Cited by 65
Welcome, M. O., & Mastorakis, N. E. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00806-x · Cited by 66
Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S.-Y., Li, Y., & He, Y.-W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00677 · Cited by 67
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
Sparks, M. A., South, A. M., Badley, A. D., Baker-Smith, C. M., BATLLE, D. C., Bozkurt, B., Cattaneo, R., Crowley, S. D., Dell’Italia, L. J., Ford, A. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15948 · Cited by 62
Next-Generation Sequencing Reveals the Progression of COVID-19
Chen, X., Kang, Y., Luo, J., Pang, K., Xu, X. Y., Wu, J., Li, X., & Jin, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.632490 · Cited by 69
Lombardi, A., Trombetta, E., Cattaneo, A., Castelli, V., Palomba, E., Tirone, M., Mangioni, D., Lamorte, G., Manunta, M., Prati, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.560330 · Cited by 62
Gheware, A., Dholakia, D., Kannan, S., Panda, L. R., Rani, R., PATTNAIK, B. R., Jain, V., Parekh, Y., Enayathullah, M. G., Bokara, K. K., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01698-9 · Cited by 68
Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
Varghese, J., Sandmann, S., Ochs, K., Schrempf, I. M., Frömmel, C., Dugas, M., Schmidt, H., Vollenberg, R., & Tepasse, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-91270-8 · Cited by 68
Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure
Durand, N., Mallea, J. M., & Zubair, A. C. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-00105-z · Cited by 61
Liuzijue is a promising exercise option for rehabilitating discharged COVID-19 patients
Tang, Y., Jiang, J. P., Shen, P., Li, M., You, H., Liu, C., Chen, L., Wang, Z., Zhou, C., & Feng, Z. (2021) · Medicine · doi:10.1097/md.0000000000024564 · Cited by 61
Pericardial Diseases in COVID19: a Contemporary Review
Furqan, M. M., Verma, B. R., Cremer, P. C., Imazio, M., & Klein, A. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01519-x · Cited by 63
Hasankhani, A., Bahrami, A., Sheybani, N., Aria, B., Hemati, B., Fatehi, F., Farahani, H. G. M., Javanmard, G., Rezaee, M., Kastelic, J. P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.789317 · Cited by 62
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Alahdal, M., & Elkord, E. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109177 · Cited by 60
Exploring the treatment of COVID ‐19 with Yinqiao powder based on network pharmacology
Lin, H., Wang, X., Liu, M., Huang, M., Shen, Z. Z., Feng, J., Yang, H., Li, Z., Gao, J., & Ye, X. (2021) · Phytotherapy Research · doi:10.1002/ptr.7012 · Cited by 61
Metadata
- Authors
- Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., Wu, H., Lin, Y., Zhang, M., Zhang, Q., Shi, M., Liu, Y., Zhou, Y., Lan, K., & Chen, Y.
- Affiliations
- Wuhan University (CN)
- Sun Yat-sen University (CN)
- BGI Group (China) (CN)
- State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University
- The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University
- Corresponding author
- Zhou, Yu
- Lan, Ke
- Chen, Yu
- ORCID
- Venue
- Emerging Microbes & Infections
- Publisher
- Informa UK Limited
- Published
- 2020-01
- Volume
- 9
- Issue
- 1
- Pages
- 761-770
- ISSN
- 2222-1751 (ISSN-L)
- PMC
- PMC7170362
- OpenAlex
- W3013843138
- Cited by
- 1,076
- References
- 53
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 68 · 2023: 121 · 2022: 206 · 2021: 370 · 2020: 272
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Emerging Microbes & Infections (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (31871316, COVID-19)
- Wuhan University
- National Science and Technology Major Project (#2018ZX10733403)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, SARS-CoV-2, bronchoalveolar lavage fluid, peripheral blood mononuclear cells, host immune response, inflammatory cytokines, chemokines, lymphopenia, apoptosis, p53 pathway, lymphocyte activation, transcriptome
- MeSH terms
- Betacoronavirus, RNA-Seq, COVID-19, SARS-CoV-2, Bronchoalveolar Lavage Fluid, Humans, Leukocytes, Mononuclear, Lymphopenia, Pneumonia, Viral, Signal Transduction, Tumor Suppressor Protein p53, Cytokines, Apoptosis, Coronavirus Infections, Chemokines, Pandemics, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review